Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-26T07:07:46.340Z Has data issue: false hasContentIssue false

Surveying Cystic Fibrosis Care Centers to Assess Adoption of Infection Prevention and Control Recommendations

Published online by Cambridge University Press:  15 April 2018

Lisa Saiman*
Affiliation:
Department of Pediatrics, Columbia University Medical Center, New York, New York Department of Infection Prevention and Control, New York-Presbyterian Hospital, New York, New York
Juyan J. Zhou
Affiliation:
Department of Pediatrics, Columbia University Medical Center, New York, New York
Xiaotong Jiang
Affiliation:
Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina
Michael R. Kosorok
Affiliation:
Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina
Marianne S. Muhlebach
Affiliation:
Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina
*
Address correspondence to Lisa Saiman, MD, MPH, Columbia University Medical Center, 630 W 168th St, PH4W-470, New York 10032 ([email protected]).

Abstract

OBJECTIVE

In 2013, the Cystic Fibrosis (CF) Foundation developed an updated guideline for infection prevention and control (IP&C) practices for CF. We sought to assess the adoption of specific recommendations by CF care centers.

METHODS

Directors of the 277 CF care centers in the United States were asked to complete a confidential online survey regarding the adoption of selected IP&C recommendations. Selected recommendations were those we considered less likely to be incorporated into a center’s written IP&C policies.

RESULTS

Center directors from 198 of 277 CF centers (71%) completed the survey between December 2015 and June 2016; pediatric and larger centers were more likely to do so. Overall, 70% have adopted ≥75% of the selected recommendations. As recommended, almost all provided education to CF center staff (98%) and patients and families (97%); fewer developed educational materials in collaboration with local IP&C teams (59%) and/or patients and families (37%). Among 108 centers with non–English-speaking patients, 65 (60%) provided educational materials in relevant languages. Most (74%) held group education events; of the 138 centers with in-person meetings, 45% allowed 1 individual with CF to attend, and 51% allowed no individuals with CF to attend. Most centers (93%) held outdoor events, and 84% allowed >1 individual with CF to attend. Audits of exam-room cleaning were performed by 49% of CF centers.

CONCLUSIONS

Cystic fibrosis centers in the United States have adopted many of the recommendations addressed in this survey. Nonetheless, these findings suggest opportunities for improvement. More CF centers should provide education to non–English-speaking patients and families, and CF centers should perform audits of room cleaning.

Infect Control Hosp Epidemiol. 2018;39:647–651

Type
Original Articles
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION. This work was presented as a poster at the North American Cystic Fibrosis Conference on October 27–29, 2016, in Orlando, Florida.

References

REFERENCES

1. Saiman, L, Siegel, J. the CF Foundation Consensus Conference on Infection Control Participants. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003;24:S6S52.Google Scholar
2. Saiman, L, Siegel, JD, LiPuma, JJ, et al. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol 2014;35:S1S67.CrossRefGoogle ScholarPubMed
3. Garber, E, Desai, M, Zhou, J, et al. Barriers to adherence to cystic fibrosis infection control guidelines. Pediatr Pulmonol 2008;43:900907.Google Scholar
4. Miroballi, Y, Garber, E, Jia, H, et al. Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families. Pediatr Pulmonol 2012;47:144152.Google Scholar
5. Jain, M, Saiman, L, Sabadosa, K, LiPuma, JJ. Point: Does the risk of cross infection warrant exclusion of adults with cystic fibrosis from cystic fibrosis foundation events? Yes. Chest 2014;145:678680.Google Scholar
6. Shepherd, SL, Goodrich, EJ, Desch, J, Quinton, PM. Point: Does the risk of cross infection warrant exclusion of adults with cystic fibrosis from cystic fibrosis foundation events? No. Chest 2014;145:680683.Google Scholar
7. Census regions and divisions of the United States. US Census Bureau website. www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf. Accessed January 17, 2017.Google Scholar
8. Infection prevention and control clinical care guidelines. Cystic Fibrosis Foundation website. www.cff.org/Care/Clinical-Care-Guidelines/Infection-Prevention-and-Control-Clinical-Care-Guidelines/Infection-Prevention-and-Control-Clinical-Care-Guidelines/. Updated 2013. Accessed October 10, 2017.Google Scholar
9. Mauger, B, Marbella, A, Pines, E, Chopra, R, Black, ER, Aronson, N. Implementing quality improvement strategies to reduce healthcare-associated infections: a systematic review. Am J Infect Control 2014;42:S274S283.CrossRefGoogle ScholarPubMed
10. Barnes, SL, Morgan, DJ, Harris, AD, Carling, PC, Thom, KA. Preventing the transmission of multidrug-resistant organisms: modeling the relative importance of hand hygiene and environmental cleaning interventions. Infect Control Hosp Epidemiol 2014;35:11561162.CrossRefGoogle ScholarPubMed
11. Carling, PC, Huang, SS. Improving healthcare environmental cleaning and disinfection: current and evolving issues. Infect Control Hosp Epidemiol 2013;34:507513.Google Scholar
12. CR Peer Connect. Cystic Fibrosis Foundation website. www.cff.org/Get-Involved/Community/CF-Peer-Connect. Accessed March 8, 2018.Google Scholar
13. Razvi, S, Quittell, L, Sewall, A, Quinton, H, Marshall, B, Saiman, L. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995–2005. Chest 2009;136:15541560.CrossRefGoogle Scholar
14. Salsgiver, EL, Fink, AK, Knapp, EA, et al. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis. Chest 2016;149:390400.Google Scholar
15. MacKenzie, T, Gifford, AH, Sabadosa, KA, et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry. Ann Intern Med 2014;161:233241.Google Scholar
Supplementary material: PDF

Saiman et al. supplementary material

Saiman et al. supplementary material

Download Saiman et al. supplementary material(PDF)
PDF 93.4 KB